Cite
OA12.03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
MLA
Kayla Guidry, et al. “OA12.03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC.” Journal of Thoracic Oncology, vol. 16, Oct. 2021, p. S869. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0f607f344e3af89723af08868c8ecd5&authtype=sso&custid=ns315887.
APA
Kayla Guidry, D. Maeda, Kwan Ho Tang, Jayu Jen, Ting Chen, James G. Christensen, Benjamin G. Neel, Han Han, Peter D. Olson, Alireza Khodadadi-Jamayran, Argus Athanas, Kwok K. Wong, John A Zebala, Yuan Hao, Shihua Li, & Carmine Fedele. (2021). OA12.03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC. Journal of Thoracic Oncology, 16, S869.
Chicago
Kayla Guidry, D. Maeda, Kwan Ho Tang, Jayu Jen, Ting Chen, James G. Christensen, Benjamin G. Neel, et al. 2021. “OA12.03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC.” Journal of Thoracic Oncology 16 (October): S869. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0f607f344e3af89723af08868c8ecd5&authtype=sso&custid=ns315887.